Show simple item record

Reduction of the number of immunocompetent cells in the acute stage of herpes zoster

dc.contributor.authorLindskov, R.en_US
dc.contributor.authorBaadsgaard, Oleen_US
dc.contributor.authorGeisler, C.en_US
dc.date.accessioned2006-09-11T18:44:55Z
dc.date.available2006-09-11T18:44:55Z
dc.date.issued1987-08en_US
dc.identifier.citationBaadsgaard, O.; Lindskov, R.; Geisler, C.; (1987). "Reduction of the number of immunocompetent cells in the acute stage of herpes zoster." Archives of Dermatological Research 279(6): 374-378. <http://hdl.handle.net/2027.42/47239>en_US
dc.identifier.issn0340-3696en_US
dc.identifier.issn1432-069Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/47239
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3499870&dopt=citationen_US
dc.description.abstractCirculating and in situ mononuclear cell subsets were phenotypically characterized during both the acure and convalescent phase of herpes zoster infections in 14 patients. In peripheral blood a significant reduction in the absolute number of Leu 4 + T cells, Leu 2a + suppressor/cytotoxic T cells, Leu 3a + helper/inducer T cells, Leu 7 + killer cells, and B1 + B cells were found during the acute stage compared to convalescents and normal controls. In contrast no change in the absolute number of MO2 + monocytes was seen in the acute stage of the disease. During convalescence a return to normal values in the lymphocyte subsets and killer cells was seen within 1–2 months after the initial disease presentation.en_US
dc.format.extent360695 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; Springer-Verlag GmbH & Co. KGen_US
dc.subject.otherDermatologyen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherB Cellsen_US
dc.subject.otherHerpes Zosteren_US
dc.subject.otherT Cellsen_US
dc.subject.otherMonoclonal Antibodiesen_US
dc.subject.otherMonocytesen_US
dc.titleReduction of the number of immunocompetent cells in the acute stage of herpes zosteren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Dermatology, Gentofte Hospital, Copenhangen; Department of Dermatology, Immunodermatology Unit, University of Michigan, R5538 Kresge 1/0530, 48109, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherDepartment of Dermatology, Gentofte Hospital, Copenhangenen_US
dc.contributor.affiliationotherDepartment of Clinical Chemistry, The Finsen Institute, Rigshospitalet, Copenhagenen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid3499870en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/47239/1/403_2004_Article_BF00412622.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00412622en_US
dc.identifier.sourceArchives of Dermatological Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.